The analysts at Barclays took a shine to Weight Watchers (NYSE:WTW) today upgrading the shares to 'equalweight' from 'underweight'.
The analysts at took a shine to Weight Watchers () today upgrading the shares to 'equalweight' from 'underweight'.
The target price was also lifted to US$14 a share from US$5.
Ealier this week, it emerged one of the most popular US talk show hosts had taken a stake in the Weight Watchers parent firm.
Oprah Winfrey, the presenter of the eponymously named show, purchased a 10% stake in the global slimming group for US$43mln and will take a seat on the board.
Also in broker world on Wednesday, drugs giant was pushed up to 'neutral' from 'underperform' by .
(TSE:RCI) gained over a percentage point to US$49.68 on the day as Macquarie raised its rating to 'outperfom' from 'neutral'.
On the flipside, CIBC is less upbeat on Valeant Pharmaceuticals International (NYSE: VRX) and downgrades it to 'sector perform' from ' sector outperform'.
Shares lost over 27% to US$106.47.